Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

C3_RESPIRATORY_INTRATHORACIC3_NAS_EXALLC

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — C39 Hospital discharge: ICD-9 — 165 Hospital discharge: ICD-8 — 1639 Cause of death: ICD-10 — C39 Cause of death: ICD-9 — 165 Cause of death: ICD-8 — 1639 Cancer registry: Topography ICD-O-3 — C39 Cancer registry: Morphology ICD-O-3 — ANY Cancer registry: Behaviour codes — 3 3 out of 7 registries used, show all original rules.	105
4. Check minimum number of events None	105
5. Include endpoints None	105
6. Filter based on genotype QC (FinnGen only)	105

Control definitions (FinnGen only)

Control exclude: C3_CANCER, C3_CANCER_WIDE_EXALLC

Extra metadata

First used in FinnGen datafreeze: DF12

NAME	C3_RESPIRATORY_INTRATHORACIC3_NAS_EXALLC
CONTROL_EXCLUDE	C3_CANCER\|C3_CANCER_WIDE_EXALLC
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	C39
HD_ICD_9	165
HD_ICD_8	1639
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	C39
COD_ICD_9	165
COD_ICD_8	1639
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO	C39
CANC_TOPO_EXCL
CANC_MORPH	ANY
CANC_MORPH_EXCL
CANC_BEHAV	3

Similar endpoints

↥

List of similar endpoints to Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers) based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	105	31	74
Unadjusted period prevalence (%)	0.03	0.01	0.03
Median age at first event (years)	68.79	61.29	71.94

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

No data available

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(4035726)

9.04

11.31

1.8

1.1

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

626

0.31

7.32

3.3

5.3

2.4

2.5

mmol/l

0.38

561

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

618

0.36

5.67

4.3

5.0

5.7

6.2

mmol/l

2.75

537

(40761511) CBC panel - Blood by Automated count

663

0.40

4.85

23.0

14.3

—

(3003434) Protein [Mass/volume] in Pleural fluid

12.37

4.34

1.1

1.2

38.5

26.4

g/l

—

(3009508) Creatinine [Moles/volume] in Urine

217

0.23

4.13

2.2

3.1

6.2

7.3

mmol/l

—

183

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

486

0.40

4.09

3.1

3.7

15.3

14.9

pmol/l

0.36

420

(40768806) Pleura Pathology biopsy report

12.60

3.81

1.3

1.2

—

(3012441) Differential panel - Pleural fluid

10.50

3.54

1.2

1.0

—

(3002385) Erythrocyte distribution width [Ratio]

497

0.45

3.46

31.4

18.0

14.3

13.9

0.85

480

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

7.40

3.42

1.0

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

330

0.36

3.41

1.6

2.1

87.3

89.6

pmol/l

—

174

(3009542) Hematocrit [Volume Fraction] of Blood

555

0.47

3.38

24.9

16.4

36.9

38.7

0.83

328

(3041096) Erythrocytes [Presence] in Urine by Automated

174

0.25

3.22

2.8

3.7

—

(3037467) Urinalysis macro (dipstick) panel - Urine

471

0.47

3.01

4.3

4.1

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

371

0.43

2.94

3.5

3.0

47.1

49.8

u/l

0.07

334

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

5.68

2.92

2.7

1.2

62.7

87.8

u/ml

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

310

0.40

2.86

3.2

2.5

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

308

0.40

2.80

7.7

4.2

2.8

2.5

ug/l

0.16

265

(3044889) 12 lead EKG panel

453

0.55

2.02

4.0

4.1

—

(3013512) EKG study

221

0.44

1.85

3.5

4.3

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

245

0.46

1.84

5.8

4.0

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

324

0.53

1.80

4.0

4.1

49.4

56.5

ng/l

0.15

242

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

3.47

1.77

1.0

1.4

—

(36660697) Celiac disease serology panel - Serum

0.00

1.75

0.0

1.2

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

160

0.40

1.73

5.3

2.6

1.1

0.9

ug/l

—

114

(3021960) Folate [Moles/volume] in Serum or Plasma

196

0.46

1.56

1.6

23.4

19.1

nmol/l

—

165

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1.92

1.50

3.0

2.1

0.8

mmol/l

0.10

(3015736) pH of Urine

257

0.55

1.35

4.7

3.7

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

2.48

1.26

1.8

3.6

—

(3000991) Gas panel - Venous blood

2.09

1.08

16.3

8.1

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.99

0.0

1.0

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

0.00

0.97

0.0

2.4

—

80.5

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

1.95

0.96

18.9

7.3

0.7

1.4

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

1.95

0.96

19.1

7.2

0.5

0.8

—

(40768804) Tissue Pathology biopsy report

188

1.51

0.95

3.0

1.7

—

(3042936) Bacteria identified in Isolate by Culture

1.64

0.83

2.8

1.6

—

(4034850)

0.00

0.80

0.0

15.0

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

0.00

0.79

0.0

1.4

—

36.0

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

0.00

0.78

0.0

1.5

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

237

0.66

0.78

4.8

2.9

—

(3002256) Pathology report gross observation

1.90

0.75

1.7

1.1

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

1.97

0.71

21.8

6.8

—

(3026008) Bacteria identified in Urine by Culture

237

0.71

0.61

2.5

2.7

—

(40758558) Short blood count panel - Blood

136

1.39

0.53

8.7

5.4

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

155

0.68

0.53

4.3

3.4

209.1

186.1

ng/l

0.04

126

(3018677) aPTT in Platelet poor plasma by Coagulation assay

109

0.62

0.52

2.3

1.6

28.9

30.1

—

104

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1.49

0.48

1.1

2.1

0.2

g/l

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1.43

0.46

1.6

1.4

—

(3019069) Monocytes/100 leukocytes in Blood

300

0.78

0.45

5.5

10.2

9.0

0.87

269

(3014111) Lactate [Moles/volume] in Serum or Plasma

1.49

0.44

20.4

5.2

1.1

1.5

mmol/l

—

(3023368) Bacteria identified in Blood by Culture

197

1.28

0.43

5.7

3.8

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

277

0.78

0.42

4.4

3.6

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

0.00

0.41

0.0

1.1

—

(3035285) Chloride [Moles/volume] in Venous blood

0.00

0.41

0.0

2.4

—

105.5

—

(3041354) Potassium [Moles/volume] in Venous blood

0.00

0.41

0.0

2.4

—

4.1

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

0.00

0.41

0.0

1.3

—

(3018572) Chloride [Moles/volume] in Blood

0.00

0.41

0.0

6.1

—

105.6

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

0.00

0.41

0.0

1.1

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

0.00

0.41

0.0

2.4

—

(3039000) Anion gap in Blood

0.00

0.41

0.0

6.1

—

9.8

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

0.00

0.41

0.0

1.1

—

(4094501)

0.00

0.41

0.0

1.1

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

0.00

0.41

0.0

1.5

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

0.00

0.41

0.0

1.3

—

(3006504) Eosinophils/100 leukocytes in Blood

297

0.79

0.41

5.5

5.2

3.0

2.9

0.01

266

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

0.00

0.40

0.0

1.3

—

(3019832) Treponema pallidum Ab [Presence] in Serum

1.45

0.40

2.8

1.7

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

0.00

0.39

0.0

1.3

—

(3007853) Bacteria identified in Skin by Aerobe culture

1.40

0.38

1.5

1.9

—

(3023520) Reticulocytes [#/volume] in Blood

0.62

0.37

2.0

2.2

74.3

63.2

e9/l

—

(3002030) Lymphocytes/100 leukocytes in Blood

302

0.82

0.35

5.3

5.4

22.8

25.5

0.69

268

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

0.66

0.34

12.8

9.7

—

(3022096) Basophils/100 leukocytes in Blood

291

0.82

0.34

5.5

5.1

0.8

0.6

0.49

262

(42870588) Differential panel, method unspecified - Blood

217

0.79

0.33

5.2

5.3

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

0.69

0.32

5.7

2.5

24.7

23.0

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

216

0.80

0.32

2.1

2.0

68.7

60.4

u/l

0.48

195

(3018010) Neutrophils/100 leukocytes in Blood

298

0.83

0.30

5.3

5.0

58.8

59.2

0.05

267

(3012544) pH of Venous blood

0.68

0.27

6.6

4.1

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

0.68

0.27

1.2

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

0.67

0.27

2.6

1.7

—

(36304419) Bacteria [Presence] in Urine

180

0.81

0.27

3.4

2.6

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

188

0.82

0.23

3.7

2.7

27.5

31.4

u/l

0.80

175

(3017143) Hepatitis C virus Ab [Presence] in Serum

1.23

0.22

3.8

1.5

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

0.00

0.21

0.0

1.5

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

0.00

0.21

0.0

1.5

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

0.00

0.21

0.0

1.5

—

(3005033) Fetal Nuchal fold Thickness US

0.00

0.21

0.0

1.5

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

0.00

0.21

0.0

1.5

—

(3000093) Morphology [Interpretation] in Blood Narrative

0.00

0.21

0.0

1.1

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

0.00

0.21

0.0

1.5

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

(3028300) Cannabinoids [Presence] in Urine

0.00

0.21

0.0

1.0

—

(3016879) Cocaine [Presence] in Urine

0.00

0.21

0.0

1.0

—

(3027944) Amphetamines [Presence] in Urine

0.00

0.21

0.0

1.0

—

(3004616) Nuclear Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

0.00

0.21

0.0

1.2

—

(3044927) Protein electrophoresis panel - Urine

0.00

0.21

0.0

1.1

—

(3027008) Opiates [Presence] in Urine

0.00

0.21

0.0

1.0

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

0.00

0.21

0.0

1.2

—

(3026389) Candida sp identified in Specimen by Organism specific culture

0.00

0.21

0.0

1.2

—

(3019230) Fractional oxyhemoglobin in Venous blood

0.00

0.21

0.0

2.6

—

58.0

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.7

—

(40767503) Oxygen content in Capillary blood by calculation

0.00

0.21

0.0

2.0

—

16.6

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

0.00

0.21

0.0

2.1

—

(3003327) Ova and parasites identified in Stool by Light microscopy

0.00

0.21

0.0

1.4

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

0.00

0.21

0.0

1.0

—

(3024928) Oxygen saturation in Venous blood

0.00

0.21

0.0

3.7

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

0.00

0.21

0.0

1.7

—

(3037756) Immunofixation for Serum or Plasma

0.00

0.21

0.0

1.2

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

0.00

0.21

0.0

1.6

—

(40760892) CBC W Ordered Manual Differential panel - Blood

115

0.76

0.21

4.9

4.4

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

0.00

0.21

0.0

1.9

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

0.00

0.21

0.0

1.2

—

(3008898) HLA-B27 [Presence]

0.00

0.21

0.0

1.2

—

(3023419) Bacteria identified in Sputum by Culture

0.00

0.20

0.0

3.2

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

0.00

0.20

0.0

1.4

—

(3004775) Volume in Urine collected for unspecified duration

0.00

0.20

0.0

2.4

—

495.6

—

(3032080) INR in Blood by Coagulation assay

288

0.87

0.20

7.4

10.8

1.4

inr

—

(3002032) Base excess in Venous blood by calculation

0.72

0.17

6.6

4.2

2.2

1.8

mmol/l

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1.19

0.17

2.0

2.3

4.3

8.0

umol/l

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

0.77

0.16

2.8

3.5

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

140

1.17

0.16

3.0

1.8

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1.18

0.16

1.9

1.6

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1.18

0.16

1.9

1.6

—

(3033658) Prothrombin time (PT) actual/Normal

145

1.12

0.10

6.4

3.1

91.7

82.9

0.86

138

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1.04

0.09

1.8

1.6

—

(3022145) Colonoscopy Study observation

0.80

0.08

1.0

1.3

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

0.80

0.08

1.6

2.0

37.8

33.4

u/l

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1.12

0.08

18.9

6.6

110.7

121.6

g/l

—

(3000494) Fungus identified in Specimen by Culture

0.85

0.08

1.2

1.6

—

(40768797) Stomach Pathology biopsy report

0.87

0.07

1.4

1.3

—

(3044640) Blood type and Crossmatch panel - Blood

190

1.07

0.04

3.3

2.0

—

(3003694) ABO and Rh group [Type] in Blood

149

0.93

0.03

1.3

1.4

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

307

0.97

0.01

12.2

4.9

1.2

mmol/l

0.28

266

(3011397) Hemoglobin [Presence] in Urine by Test strip

142

0.98

0.00

5.7

3.4

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

114

0.96

0.00

1.8

1.7

—

(21494434) Karyotype in Bone marrow

0.00

0.0

1.1

—

(3000764) Benzodiazepines [Presence] in Urine

0.00

0.0

1.0

—

(3005570) Glucose [Moles/volume] in Urine

0.00

0.0

2.2

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.0

—

(21491868) Cryoglobulin [Mass/volume] in Serum

0.00

0.0

1.0

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

0.00

0.0

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.0

1.0

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

0.00

0.0

1.2

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.0

—

(3025130) Human papilloma virus identified in Specimen

0.00

0.0

2.2

—

(3003129) Base excess in Capillary blood by calculation

0.00

0.0

1.2

—

2.6

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

0.00

0.0

1.3

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

0.00

0.0

1.0

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

0.00

0.0

2.3

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

0.00

0.0

1.2

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

0.00

0.0

1.2

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

0.00

0.0

1.4

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

0.00

0.0

1.0

—

(21494890) Protein electrophoresis panel - 24 hour Urine

0.00

0.0

1.2

—

(3029075) Extractable nuclear Ab panel - Serum

0.00

0.0

1.0

—

(3012565) Volume of 24 hour Urine

0.00

0.0

1.8

—

2570.0

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

0.00

0.0

1.1

—

(3011648) Oxygen content in Venous blood

0.00

0.0

2.1

—

10.1

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.1

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

0.84

0.00

3.0

1.6

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

0.00

0.0

1.0

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.1

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

0.00

0.0

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.0

1.0

—

(3020876) Protein [Mass/time] in 24 hour Urine

0.00

0.0

2.2

—

(3020491) Glucose [Moles/volume] in Blood

0.00

0.0

2.5

—

6.2

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

0.00

0.0

2.3

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

0.00

0.0

1.0

—

26.6

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

0.00

0.0

1.0

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

0.00

0.0

1.0

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

0.00

0.0

1.2

—

17.5

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.0

1.0

—

(3045142) Bone marrow Pathology biopsy report

0.00

0.0

1.0

—

(3019225) pH of Specimen

0.89

0.00

2.5

3.1

—

(3026470) Cobalt [Mass/volume] in Blood

0.00

0.0

1.6

—

1.7

—

(4062490)

0.00

0.0

1.3

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.0

1.0

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

0.00

0.0

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.0

1.0

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

0.00

0.0

1.0

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

0.00

0.0

1.6

—

19.4

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

0.00

0.0

1.7

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

0.00

0.0

1.4

—

34.4

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

0.00

0.0

1.9

—

(3039443) Prostate specific Ag panel - Serum or Plasma

0.00

0.0

1.5

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: C3_RESPIRATORY_INTRATHORACIC3_NAS_EXALLC – Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers) (C3_RESPIRATORY_INTRATHORACIC3_NAS_EXALLC)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

LabWAS

Mortality – FinRegistry

Relationships between endpoints